KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other financing activities: 2018-2019

Historic Other financing activities for Moderna (MRNA) over the last 1 years, with Dec 2019 value amounting to -$3.7 million.

  • Moderna's Other financing activities fell 137.20% to -$3.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $9.9 million, marking a year-over-year change of. This contributed to the annual value of $11.6 million for FY2018, which is 327.13% up from last year.
  • Latest data reveals that Moderna reported Other financing activities of -$3.7 million as of Q4 2019, which was down 200.00% from $3.7 million recorded in Q2 2019.
  • Moderna's 5-year Other financing activities high stood at $9.9 million for Q4 2018, and its period low was -$3.7 million during Q4 2019.
  • Its 2-year average for Other financing activities is $2.3 million, with a median of $1.7 million in 2018.
  • Examining YoY changes over the last 5 years, Moderna's Other financing activities showed a top increase of 18,290.00% in 2019 and a maximum decrease of 137.20% in 2019.
  • Moderna's Other financing activities (Quarterly) stood at $9.9 million in 2018, then slumped by 137.20% to -$3.7 million in 2019.
  • Its last three reported values are -$3.7 million in Q4 2019, $3.7 million for Q2 2019, and $9.9 million during Q4 2018.